NEOSANA
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Dec 2022)
What this means for you
This application is over — abandoned 12 Dec 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88402086
- Mark type
- Stylized text
- Filed
- 25 Apr 2019
- Published for opposition
- 10 Sept 2019
- Abandoned
- 12 Dec 2022
- Attorney of record
- Jun Hyuk (Zach) Hong
Goods and services
- Class 005 — Pharmaceuticals: Medical device for treating wounds and repairing soft tissue, namely, surgical implants, surgical mesh, wound matrices, and wound scaffolds comprising biological material; natural biomaterials comprising living tissue for soft tissue repair, wound management and dermal reconstruction; natural biomaterials comprising living tissue for augmentation of soft tissue for medical purposes; implants comprising living tissue; skin growth and repair media consisting of biological materials for medical purposes; implantable scaffolds and matrices comprising living tissue for tissue repair, wound management and dermal reconstruction; regenerative products and materials for use in surgical procedures and wound management, namely, scaffolds and matrices made of biological materials for promoting and facilitating soft tissue growth, regeneration and repair
- Class 010 — Medical apparatus: Artificial biomaterials for soft tissue repair, wound management and dermal reconstruction; artificial biomaterials for augmentation of soft tissue for medical purposes; implants comprising natural, non-living materials; implants consisting of artificial materials; biodegradable soft tissue repair, wound management, and dermal reconstruction implants; permanent soft tissue repair, wound management, and dermal reconstruction implants; surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; surgical implants and mesh made of artificial electrospun biomaterial for use in soft tissue repair or the reconstruction of soft tissue deficiencies; medical devices and apparatuses, namely, surgical implants or mesh made of artificial biomaterial for use in repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor; surgical mesh comprised primarily of artificial materials; implantable scaffolds and matrices comprising artificial materials for soft tissue repair, wound management and dermal reconstruction; regenerative products and materials for use in surgical procedures and wound management, namely, synthetic scaffolds and matrices promoting and facilitating soft tissue growth, regeneration and repair; medical device for treating wounds and repairing soft tissue, namely, surgical implants, surgical mesh, wound matrices, and wound scaffolds comprising artificial material; natural, non-living biomaterials for soft tissue repair, wound management and dermal reconstruction; natural, non-living biomaterials for augmentation of soft tissue for medical purposes
Owner
- Acera Surgical, Inc., St. Louis, MO, US
- Acera Surgical, Inc., Creve Coeur, MO, US
Prosecution history
- 12 Dec 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 Dec 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 10 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2022 — SOU EXTENSION 5 GRANTED
- 02 May 2022 — SOU EXTENSION 5 FILED
- 07 May 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 May 2022 — SOU TEAS EXTENSION RECEIVED
- 16 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Oct 2021 — SOU EXTENSION 4 GRANTED
- 14 Oct 2021 — SOU EXTENSION 4 FILED
- 14 Oct 2021 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2021 — SOU EXTENSION 3 GRANTED
- 04 Feb 2021 — SOU EXTENSION 3 FILED
- 04 Feb 2021 — SOU TEAS EXTENSION RECEIVED